The Goldman Sachs Group Upgrades Mobia Medical (NASDAQ:MOBI) to Strong-Buy

Mobia Medical (NASDAQ:MOBI) was upgraded by investment analysts at The Goldman Sachs Group to a “strong-buy” rating in a report issued on Tuesday,Zacks.com reports.

Several other equities research analysts also recently issued reports on the stock. BTIG Research started coverage on shares of Mobia Medical in a research report on Tuesday. They set a “buy” rating and a $19.00 price objective for the company. Wall Street Zen upgraded shares of Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. Bank of America started coverage on shares of Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $16.00 price target on the stock. Wolfe Research started coverage on shares of Mobia Medical in a research note on Tuesday. They issued an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of Mobia Medical in a research note on Tuesday. They issued an “overweight” rating and a $15.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company’s stock. Based on data from MarketBeat, Mobia Medical currently has an average rating of “Buy” and a consensus target price of $20.25.

Mobia Medical Stock Down 0.4%

Shares of MOBI stock opened at $13.73 on Tuesday. Mobia Medical has a 12-month low of $10.19 and a 12-month high of $14.77. The firm has a market cap of $454.26 million, a PE ratio of 66.00 and a beta of 2.84.

Insider Transactions at Mobia Medical

In related news, Director William T. Harrington bought 533,333 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the purchase, the director owned 2,006,716 shares in the company, valued at $30,100,740. This represents a 36.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dana G. Jr. Mead bought 7,000 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were bought at an average price of $15.00 per share, with a total value of $105,000.00. Following the purchase, the director owned 7,000 shares in the company, valued at $105,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have acquired 1,268,332 shares of company stock valued at $19,024,980.